<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.marketbeat.com/feed/</title><link>https://www.marketbeat.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Tue, 09 Sep 2025 10:53:00 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing</title><link>https://www.marketbeat.com/originals/jobys-stock-is-quiet-but-a-storm-of-catalysts-is-brewing/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>Joby Aviation's stock consolidation overlooks a series of major catalysts, including a landmark defense demonstration that expands its long-term poten...</description><pubDate>Tue, 09 Sep 2025 10:44:00 GMT</pubDate></item><item><title>Mortgage Pressures Ease, 3 Stocks to Rally on Lower Rates</title><link>https://www.marketbeat.com/stock-ideas/mortgage-pressures-ease-3-stocks-to-rally-on-lower-rates/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>As mortgage rates start to come down ahead of the big Fed decision, these three stocks show several signs of running into new highs shortly.</description><pubDate>Tue, 09 Sep 2025 10:29:00 GMT</pubDate></item><item><title>Take the Money and Run: Strategy Stock Looks Tapped Out</title><link>https://www.marketbeat.com/originals/take-the-money-and-run-strategy-stock-looks-tapped-out/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Strategy stock is being seen as riskier in today's market environment, despite the potential for rate cuts coming from the Fed, a warning sign for inv...</description><pubDate>Tue, 09 Sep 2025 09:31:00 GMT</pubDate></item><item><title>Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver</title><link>https://www.marketbeat.com/originals/novartis-moonshot-cancer-therapy-could-be-future-growth-driver/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Novartis is betting big on radioligand cancer therapy, but while the long-term growth story looks strong, NVS stock may face a short-term pullback</description><pubDate>Tue, 09 Sep 2025 08:16:00 GMT</pubDate></item><item><title>Why These Banking Stocks Could Soar on Rate Cuts</title><link>https://www.marketbeat.com/stock-ideas/why-these-banking-stocks-could-soar-on-rate-cuts/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>As markets prepare for the Fed to cut interest rates in the United States, savvy investors will position their portfolios in these banking stocks.</description><pubDate>Tue, 09 Sep 2025 07:07:00 GMT</pubDate></item></channel></rss>